New Details on the Revision of USP Chapter 1

Recommendation
13/14 May 2025
GM Requirements for Planning, Qualification and Operation
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
05.02.2025WHO publishes Guideline on Continuous Manufacturing
29.01.2025FDA publishes Final Version of AMT (Advanced Manufacturing Technologies) Guideline
22.01.2025GMP Violations at Turkish OTC Manufacturer
15.01.2025Pharmaceutical Manufacturer obstructs FDA Inspection
11.12.2024Warning Letter to Indian Manufacturer of Sterile Ophthalmic Drop Products
06.11.2024FDA Warning Letter to a US Manufacturer of Medical Gases